" class="no-js "lang="en-US"> CEO Archives - Medtech Alert
Monday, June 17, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Amarna Therapeutics Announces Appointment of Dr. Henk Streefkerk as New CEO

Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare […]

ENSEM Announces the Promotion of Shengfang Jin, PhD to President & Chief Executive Officer

Ensem Therapeutics, a biotechnology company focusing on high-value and difficult-to-drug oncology targets, today announced the […]

Visgenx Appoints William Pedranti as Chief Executive Officer

Visgenx, a biotechnology company focused on developing gene therapies for degenerative retinal diseases, today announced […]

HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer

HuidaGene Therapeutics, a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, […]

Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer and Other Leadership Appointments

Obsidian Therapeutics, a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the […]

Niklas Prager Appointed New CEO of SmartCella

SmartCella Holding AB has today announced that Niklas Prager has been appointed as the new […]

Vicinitas Therapeutics Appoints Christian Hofmann, Ph.D., as Chief Executive Officer

Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel […]

Engimmune Therapeutics Appoints Dr. Lars Nieba as Chief Executive Officer

Engimmune Therapeutics, a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, today announces the […]

Standigm Announces Younsung Choo as Chief Executive Officer (CEO)

Standigm, a company using artificial intelligence (AI) technology for drug discovery and development, announced that Younsung […]

Abivax Appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair

Abivax, a Phase 3 clinical-stage biotechnology company focused on developing therapeutics that modulate the immune […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more